Synapse - Works

Results (4297)

Differences in disease characteristics, treatment patterns, and outcomes between men (M) and women (W) with follicular lymphoma (FL): Prospective evaluation of 2,650 US patients (pts)

Meeting Abstract

Nabhan, C.; Byrtek, M.; Dawson, K. L.; Zhou, X. L.; Ziemiecki, R.; Zelenetz, A. D.; Friedberg, J. W.; Cerhan, J. R.; Flowers, C.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Monitoring PIK3CA mutant allele fraction (AF) in cell-free DNA (cfDNA) in metastatic breast cancer (MBC) patients treated with PI3K alpha-inhibitor plus letrozole (L) or exemestane (E)

Meeting Abstract

Moynahan, M. E.; Sung, P.; Asham, M.; Zamora, S.; Shah, P. D.; Modi, S.; Lake, D.; D'Andrea, G.; Goldfarb, S. B.; Chandarlapaty, S.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Nivolumab for metastatic renal cell carcinoma (mRCC): Results of a randomized, dose-ranging phase II trial

Meeting Abstract

Motzer, R. J.; Rini, B. I.; McDermott, D. F.; Redman, B. G.; Kuzel, T.; Harrison, M. R.; Vaishampayan, U. N.; Drabkin, H. A.; George, S.; Logan, T. F.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Breast cancer following spinal radiotherapy for a childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)

Meeting Abstract

Moskowitz, C. S.; Malhotra, J.; Chou, J. F.; Wolden, S. L.; Stovall, M.; Armstrong, G. T.; Leisenring, W. M.; Neglia, J. P.; Robison, L. L.; Oeffinger, K. C.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Sensitivity analyses for radiographic progression-free survival (rPFS): Results from the phase 3 PREVAIL trial comparing enzalutamide to placebo

Meeting Abstract

Morris, M. J.; Loriot, Y.; Beer, T. M.; Higano, C. S.; Armstrong, A. J.; Sternberg, C. N.; de Bono, J. S.; Tombal, B. F.; Noonberg, S. B.; Mansbach, H. H.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A randomized, open label, multicenter, phase 3, 2-arm study of androgen deprivation with leuprolide (L), +/- docetaxel (D) for clinically asymptomatic prostate cancer (PC) subjects with a rising PSA following definitive local therapy: Safety results

Meeting Abstract

Morris, M. J.; Gleave, M. E.; Armstrong, A. J.; Carducci, M. A.; Saad, F.; Lacuna, K. P.; Scher, H. I.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib

Meeting Abstract

Morikawa, A.; Jhaveri, K. L.; Patil, S.; Chen, M.; Mcdonnell, E.; Neville, D. A.; Mak, F. M.; Gansukh, B.; Humm, J. L.; Holodny, A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

The MEK Inhibitor in Low-Grade Serous Ovarian Cancer (MILO)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician's choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum

Meeting Abstract

Monk, B. J.; Grisham, R. N.; Marth, C.; Banerjee, S. N.; Hilpert, F.; Coleman, R. L.; Pujade-Lauraine, E.; Plgnata, S.; Mirza, M. R.; Oza, A. M.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Correlation of tumor-derived circulating cell free DNA (cfDNA) measured by digital PCR (DigPCR) with tumor burden measured radiographically in patients (pts) with BRAF(V600E)mutated melanoma (mel) treated with RAF inhibitor (RAFi) and/or ipilimumab (Ipi)

Meeting Abstract

Momtaz, P.; Gaskell, A. A.; Merghoub, T.; Viale, A.; Chapman, P. B.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Multiplatform molecular profiling of 2,400 pancreatic adenocarcinomas to identify targets for therapeutic intent

Meeting Abstract

Millis, S. Z.; Arguello, D.; Lowery, M. A.; O'Reilly, E. M.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save